- Home
- KTTA vs AKAN Comparison
KTTA vs AKAN Comparison
Compare KTTA & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- AKAN
- Stock Information
- Founded
- KTTA 2020
- AKAN 2021
- Country
- KTTA United States
- AKAN United Kingdom
- Employees
- KTTA N/A
- AKAN N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- AKAN Medicinal Chemicals and Botanical Products
- Sector
- KTTA Health Care
- AKAN Health Care
- Exchange
- KTTA Nasdaq
- AKAN Nasdaq
- Market Cap
- KTTA 2.6M
- AKAN 2.4M
- IPO Year
- KTTA 2021
- AKAN 2022
- Fundamental
- Price
- KTTA $1.30
- AKAN $1.75
- Analyst Decision
- KTTA
- AKAN
- Analyst Count
- KTTA 0
- AKAN 0
- Target Price
- KTTA N/A
- AKAN N/A
- AVG Volume (30 Days)
- KTTA 3.3M
- AKAN 120.7K
- Earning Date
- KTTA 03-28-2025
- AKAN 02-28-2025
- Dividend Yield
- KTTA N/A
- AKAN N/A
- EPS Growth
- KTTA N/A
- AKAN N/A
- EPS
- KTTA N/A
- AKAN N/A
- Revenue
- KTTA N/A
- AKAN $2,508,317.00
- Revenue This Year
- KTTA N/A
- AKAN N/A
- Revenue Next Year
- KTTA N/A
- AKAN N/A
- P/E Ratio
- KTTA N/A
- AKAN N/A
- Revenue Growth
- KTTA N/A
- AKAN N/A
- 52 Week Low
- KTTA $1.25
- AKAN $1.22
- 52 Week High
- KTTA $9.25
- AKAN $47.52
- Technical
- Relative Strength Index (RSI)
- KTTA 30.34
- AKAN 56.48
- Support Level
- KTTA $1.32
- AKAN $1.46
- Resistance Level
- KTTA $1.38
- AKAN $1.78
- Average True Range (ATR)
- KTTA 0.26
- AKAN 0.10
- MACD
- KTTA -0.05
- AKAN 0.00
- Stochastic Oscillator
- KTTA 1.92
- AKAN 65.91
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.